Matches in Nanopublications for { ?s ?p "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP356732.RAhd7dhQqEt-aRsQiu-qjsuLUtK8_P9UYTRnqauWeCzVM130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356732.RAhd7dhQqEt-aRsQiu-qjsuLUtK8_P9UYTRnqauWeCzVM130_provenance.
- NP1051377.RAXP4jeC94qNMznLbDja45q1VoBZcNaFAMCNB4KjpivV8130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051377.RAXP4jeC94qNMznLbDja45q1VoBZcNaFAMCNB4KjpivV8130_provenance.
- NP676775.RAMJ1-D9xpBvnSGyMjy-OR9nyGGB6p1oB6I81F0UKnkWY130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676775.RAMJ1-D9xpBvnSGyMjy-OR9nyGGB6p1oB6I81F0UKnkWY130_provenance.
- NP1051375.RABijc_5HaAK_AIBqHqS3OnxJqZtT6FT8k3Gv--Hzct1s130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051375.RABijc_5HaAK_AIBqHqS3OnxJqZtT6FT8k3Gv--Hzct1s130_provenance.
- NP356419.RAyuBBnDYctYYg3Dwu1Ljkf1itaiv7O_j_POQqB7K-UjM130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356419.RAyuBBnDYctYYg3Dwu1Ljkf1itaiv7O_j_POQqB7K-UjM130_provenance.
- NP1051376.RA7qSTl9z8ynDISeo_p7512iQVdvA_a6Hvz36VzvHkd84130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051376.RA7qSTl9z8ynDISeo_p7512iQVdvA_a6Hvz36VzvHkd84130_provenance.
- NP871490.RA39ONh7acMzXnRdV6epC9tUKtdBai9tsxavZmMT4Q3io130_assertion description "[Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871490.RA39ONh7acMzXnRdV6epC9tUKtdBai9tsxavZmMT4Q3io130_provenance.